Promote COVID-19 Vaccination for Older Adults in China

Shujie Zang, Xu Zhang, Zhiqiang Qu, Xi Chen, Zhiyuan Hou, Shujie Zang, Xu Zhang, Zhiqiang Qu, Xi Chen, Zhiyuan Hou

No abstract available

Keywords: COVID-19 vaccination; China; older adults; promotion.

Figures

Figure 1
Figure 1
Percentages of Chinese older adults completing COVID-19 vaccination from January to August 2022.

References

    1. COVID-19 Dashboard. Center for systems science and engineering at Johns Hopkins University. 2022. https://coronavirus.jhu.edu/map.html. [2022-6-5].

    1. Covino M, Russo A, Salini S, De Matteis G, Simeoni B, Della Polla D, et al Frailty assessment in the emergency department for risk stratification of COVID-19 patients aged ≥80 years. J Am Med Dir Assoc. 2021;22(9):1845–52.e1. doi: 10.1016/j.jamda.2021.07.005.
    1. Liu SJ, Xu EP, Liu Y, Xu YY, Wang J, Du J, et al Factors associated with pneumococcal vaccination among an urban elderly population in China. Hum Vacc Immunother. 2014;10(10):2994–9. doi: 10.4161/21645515.2014.972155.
    1. Wagner AL, Montgomery JP, Xu WT, Boulton ML Influenza vaccination of adults with and without high-risk health conditions in China. J Public Health. 2017;39(2):358–65. doi: 10.1093/pubmed/fdw041.

    1. National Health Commission. Transcript of regular press conference on Apr 8, 2021. 2021. http://www.nhc.gov.cn/xcs/s3574/202104/0c1cf92f2b7b4cfe890234a1c3d5593f.shtml. [2022-6-26]. (In Chinese).

    1. Kidd M, De Toca L Editorial: the contribution of Australia’s general practitioners to the COVID-19 vaccine rollout. Aust J Gen Pract. 2021;50(12):871–2. doi: 10.31128/AJGP-11-21-6235.
    1. Meng ZG, Shan SJ, Zhang RL China's COVID-19 vaccination strategy and its impact on the global pandemic. Risk Manag Healthc Policy. 2021;14:4649–55. doi: 10.2147/RMHP.S338701.
    1. Wagner AL, Porth JM, Wu ZK, Boulton ML, Finlay JM, Kobayashi LC Vaccine hesitancy during the COVID-19 pandemic: a latent class analysis of middle-aged and older US adults. J Community Health. 2022;47(3):408–15. doi: 10.1007/s10900-022-01064-w.
    1. Gatwood J, McKnight M, Fiscus M, Hohmeier KC, Chisholm-Burns M Factors influencing likelihood of COVID-19 vaccination: a survey of Tennessee adults. Am J Health Syst Pharm. 2021;78:879–89. doi: 10.1093/ajhp/zxab099.

    1. McMenamin ME, Nealon J, Lin Y, Wong JY, Cheung JK, Lau EHY, et al. Vaccine effectiveness of one, two, and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong: a population-based observational study. Lancet Infect Dis 2022. http://dx.doi.org/10.1016/S1473-3099(22)00345-0.

    1. China Government Website. Transcript of press conference of the joint prevention and control mechanism of the state council on Mar 25, 2022. 2022. http://www.gov.cn/xinwen/gwylflkjz189/index.htm. [2022-9-1]. (In Chinese).

    1. Wang ZX, Fang Y, Yu FY, Chan PSF, Chen SY, Sun FH Facilitators and barriers to take up a COVID-19 vaccine booster dose among community-dwelling older adults in Hong Kong: a population-based random telephone survey. Vaccines. 2022;10(6):966. doi: 10.3390/VACCINES10060966.

    1. National Health Commission. Knowledge about monitoring suspected adverse reactions following vaccination. 2016. http://www.nhc.gov.cn/xcs/s3574/201604/9ee6152c8e6e45a38737f1bf4120e504.shtml. [2022-7-19]. (In Chinese).

    1. Centers for Disease Control and Prevention. Vaccine adverse event reporting system (VAERS). 2021. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/vaers.html. [2022-7-16].

    1. Centers for Disease Control and Prevention. V-safe after vaccination health checker. 2022. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/vsafe.html. [2022-7-19].

    1. Mazur A, Benitez S, Chuffart-Finsterwald S, La Rotta R, Hampton LM COVAX no fault compensation program for COVID-19 vaccine injuries in 92 low and middle income countries. Vaccine. 2021;39(49):7128–30. doi: 10.1016/j.vaccine.2021.10.047.
    1. Tangcharoensathien V, Sachdev S, Viriyathorn S, Sriprasert K, Kongkam L, Srichomphu K, et al Universal access to comprehensive COVID-19 services for everyone in Thailand. BMJ Glob Health. 2022;7:e009281. doi: 10.1136/bmjgh-2022-009281.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera